Related Experiment Video
Updated: Oct 11, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Abstract:
The new mRNA vaccines for COVID-19 are highly effective at giving people immunity against the disease. But as with all other vaccines, that immunity is not 100% for everyone who receives them.
Insights
New messenger RNA (mRNA) vaccines for COVID-19 offer strong immunity but do not guarantee 100% protection for all individuals. Vaccine effectiveness varies, highlighting the need for continued public health measures.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- COVID-19 remains a significant global health concern.
- Messenger RNA (mRNA) vaccines represent a novel approach to infectious disease prevention.
- High vaccine efficacy is crucial for controlling pandemics.
Purpose of the Study:
- To evaluate the effectiveness of new mRNA vaccines against COVID-19.
- To understand the extent of immunity conferred by mRNA vaccination.
- To identify factors influencing vaccine-induced protection.
Main Methods:
- Analysis of clinical trial data for mRNA COVID-19 vaccines.
- Assessment of immune response markers post-vaccination.
- Review of real-world effectiveness studies.
Main Results:
- mRNA vaccines demonstrate high efficacy in generating immunity against COVID-19.
- Individual immune responses and protection levels can vary.
- Complete protection is not achieved in all vaccinated individuals.
Conclusions:
- The new mRNA vaccines are a powerful tool in combating COVID-19.
- Understanding variable immune responses is essential for optimizing vaccination strategies.
- Continued research into vaccine effectiveness and breakthrough infections is warranted.
Related Concept Videos
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Urinary Tract Infection IV: Nursing Management
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

